The Shanghai Composite Index fluctuated and adjusted, falling by 0.46%, while the Fujian and lithium battery sectors strengthened against the trend

Today, the market experienced fluctuations and adjustments, with the three major indices slightly declining. The Shanghai Composite Index fell by 0.46%, the Shenzhen Component Index fell by 0.11%, and the ChiNext Index fell by 0.2%. Local stocks in Fujian and the lithium battery sector showed strength against the trend, with multiple stocks hitting the daily limit. AI application sectors performed actively. Pharmaceutical stocks collectively adjusted, with SSSW falling over 10%. Individual stocks showed mixed performance, with a trading volume reaching 1.93 trillion

SSSW obtained two medical device registration certificates

SSSW recently obtained two medical device registration certificates issued by the National Medical Products Administration, including an adenovirus antigen detection kit and seven nucleic acid detection kits for respiratory pathogens. The acquisition of these registration certificates will enrich the company's product variety, enhance its competitiveness in the in vitro diagnostic field, and help improve its market expansion capabilities

SSSW: Director and Deputy General Manager Liu Zhonghua passed away suddenly due to illness at the age of 56

On the evening of September 12, SSSW announced the obituary stating that the company's director and deputy general manager Liu Zhonghua passed away due to a sudden illness in the early hours of September 12, 2025, at Taizhou People's Hospital, at the age of 56. As of the disclosure date, Liu Zhonghua directly held 2,152,512 shares of the company, accounting for 2.57% of the company's total share capital. His shares will be handled in accordance with relevant laws and regulations

SSSW's Deputy General Manager Liu Zhonghua passed away suddenly due to illness at the age of 56

SSSW's Deputy General Manager Liu Zhonghua passed away due to a sudden illness in the early hours of September 12, 2025, at Taizhou People's Hospital, at the age of 56. He was an expert in molecular biology in China, engaged in virology and molecular biology research for a long time, previously worked at the Institute of Pathogen Biology, Chinese Academy of Medical Sciences, and conducted collaborative research in the United States from 2008 to 2009. He joined SSSW in 2010

SSSW: Some directors, supervisors, and all senior management voluntarily reduced their salaries, with the annual salary of the honorary chairman and chairman being cut by 50%